S&P 500

5.464,62

-0,16%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) Notícias

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:LGNZZ

1

Data	Hora	Fonte	Título	Código	Companhia
18/06/2024	22:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
18/06/2024	18:14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
13/05/2024	19:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/05/2024	17:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
05/06/2020	17:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/05/2020	17:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
06/05/2020	17:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/04/2020	17:10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/04/2020	17:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
27/02/2020	19:38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
14/02/2020	15:19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
14/02/2020	13:34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
13/02/2020	13:09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
06/12/2018	19:10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/08/2018	13:41	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
03/07/2018	19:48	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
02/11/2017	08:03	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
15/11/2016	09:06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
09/11/2016	11:31	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
29/07/2016	17:32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
24/05/2016	14:00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
25/01/2016	17:39	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
08/01/2016	19:08	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)